Qube Research & Technologies LTD Compass Pathways PLC Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Compass Pathways PLC stock. As of the latest transaction made, Qube Research & Technologies LTD holds 19,280 shares of CMPS stock, worth $164,651. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,280Holding current value
$164,651% of portfolio
0.0%Shares
10 transactions
Others Institutions Holding CMPS
# of Institutions
144Shares Held
29.3MCall Options Held
156KPut Options Held
563K-
Tcg Crossover Management, LLC Palo Alto, CA3.86MShares$32.9 Million4.93% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.67MShares$31.3 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.38MShares$28.9 Million0.01% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.34MShares$19.9 Million0.81% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.1MShares$17.9 Million0.16% of portfolio
About COMPASS Pathways plc
- Ticker CMPS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 42,522,400
- Market Cap $363M
- Description
- COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...